数据链接：
官方服务：
资源简介：
Patient’s knowledge of taking an anticoagulant.
应用场景：
创建时间：
2017-04-07
相关数据集
Anticoagulation Therapy in Patients with Non-valvular Atrial Fibrillation in a Private Setting in Brazil: A Real-World Study
Abstract Background: The safety and effectiveness of warfarin depend on anticoagulation control quality. Observational studies associate poor control with increased morbidity, mortality and healthcar
NIAID Data Ecosystem90
Mediation analysis on effect of time within therapeutic range on the increased risks of major adverse cardiovascular events and major bleeding complications in patients with chronic kidney disease in a nested case-control study.
Model 1 includes age, gender, hypertension, the use of platelet-inhibitors, diabetes mellitus and congestive heart failure.Model 2 includes model 1 + time within therapeutic range over entire treatmen
Figshare2015-12-02 更新40
Description of the Delphi expert participants.
BackgroundThe Anticoagulation Stewardship Program (ASP) improves clinical outcomes, promotes patient safety, and supports healthcare systems in delivering high-quality, evidence-based anticoagulation
Figshare2025-12-03 更新30
A cross-sectional evaluation of five warfarin anticoagulation services in Uganda and South Africa
Introduction Warfarin is the most commonly prescribed oral anticoagulant in sub-Saharan Africa and requires ongoing monitoring. The burden of both infectious diseases and non-communicable diseases is
NIAID Data Ecosystem60
Baseline characteristics of patients with de novo use of dabigatran and prior users of dabigatran.
Prior users if they had been on dabigatran within six months prior to ablation date, the rest of the patients were identified as de novo users.
NIAID Data Ecosystem30
